Optimal Surface Marker Locations for Tumor Motion Estimation in Lung Cancer Radiotherapy

TL;DR

This paper presents an algorithm that automatically identifies a sparse set of external surface marker locations to accurately predict lung tumor motion during radiotherapy, optimizing marker placement for better treatment precision.

Contribution

The work introduces a novel optimization-based method for selecting minimal surface markers with high predictive power for internal tumor motion in lung cancer patients.

Findings

6 to 7 markers predict tumor location within 1mm error

Markers are located in areas with high correlation to tumor motion

Method tested successfully on clinical 4DCT data

Abstract

Using fiducial markers on patient's body surface to predict the tumor location is a widely used approach in lung cancer radiotherapy. The purpose of this work is to propose an algorithm that automatically identifies a sparse set of locations on the patient's surface with the optimal prediction power for the tumor motion. The sparse selection of markers on the external surface and the assumed linear relationship between the marker motion and the internal tumor motion are represented by a prediction matrix. Such a matrix is determined by solving an optimization problem, where the objective function contains a sparsity term that penalizes the number of markers chosen on the patient's surface. The performance of our algorithm has been tested on realistic clinical data of four lung cancer patients. Thoracic 4DCT scans with 10 phases are used for the study. On a reference phase, a grid of points are casted on the patient's surface (except for patient's back) and propagated to other phases via deformable image registration of the corresponding CT images. Tumor locations at each phase are also manually delineated. We use 9 out of 10 phases of the 4DCT images to identify a small group of surface markers that are most correlated with the motion of the tumor, and find the prediction matrix at the same time. The 10th phase is then used to test the accuracy of the prediction. It is found that on average 6 to 7 surface markers are necessary to predict tumor locations with a 3D error of about 1mm. In addition, the selected marker locations lie closely in those areas where surface point motion has a high correlation with the tumor motion. Our method can automatically select sparse locations on patient's external surface and estimate a correlation matrix based on 4DCT, so that the selected surface locations can be used to place fiducial markers to optimally predict internal tumor motions.